The purpose of this study is to demonstrate the usability of the system.
Age 40 to 70
Prior syringe skills
Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center
| Descriptive Information | ||||
|---|---|---|---|---|
| Brief Title ICMJE | Caverject User Study | |||
| Official Title ICMJE | Representative Users Study Of Operating Characteristics Of The Caverject Delivery System. | |||
| Brief Summary | The purpose of this study is to demonstrate the usability of the system. | |||
| Detailed Description | demonstrate usability | |||
| Study Type ICMJE | Interventional | |||
| Study Phase | Phase 3 | |||
| Study Design ICMJE | Allocation: Non-Randomized Intervention Model: Single Group Assignment Masking: None (Open Label) |
|||
| Condition ICMJE | Erectile Dysfunction | |||
| Intervention ICMJE | Other: delivery system
syringe
|
|||
| Study Arms | Experimental: Caverject Impulse
representative users
Intervention: Other: delivery system
|
|||
| Publications * | Not Provided | |||
|
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
||||
| Recruitment Information | ||||
| Recruitment Status ICMJE | Completed | |||
| Enrollment ICMJE | 48 | |||
| Completion Date | February 2011 | |||
| Primary Completion Date | February 2011 (Final data collection date for primary outcome measure) | |||
| Eligibility Criteria ICMJE |
Inclusion Criteria: Age 40 to 70 Exclusion Criteria: Prior syringe skills |
|||
| Sex/Gender |
|
|||
| Ages | 40 Years to 70 Years (Adult, Senior) | |||
| Accepts Healthy Volunteers | Yes | |||
| Contacts ICMJE | Contact information is only displayed when the study is recruiting subjects | |||
| Listed Location Countries ICMJE | United States | |||
| Removed Location Countries | ||||
| Administrative Information | ||||
| NCT Number ICMJE | NCT01008605 | |||
| Other Study ID Numbers ICMJE | A6711035 | |||
| Has Data Monitoring Committee | No | |||
| U.S. FDA-regulated Product | Not Provided | |||
| IPD Sharing Statement | Not Provided | |||
| Responsible Party | Pfizer | |||
| Study Sponsor ICMJE | Pfizer | |||
| Collaborators ICMJE | Not Provided | |||
| Investigators ICMJE |
|
|||
| PRS Account | Pfizer | |||
| Verification Date | April 2012 | |||
|
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |
||||
Contact a representative by phone, email, or visiting thte study website. To get updates and notications about this trail, sign up using the form below.
Pfizer Clinical Trials Contact Center
1-800-718-1021
